| CTRI Number |
CTRI/2026/01/100893 [Registered on: 12/01/2026] Trial Registered Prospectively |
| Last Modified On: |
12/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Commonness of Ringworm infection and effectiveness of antifungal medicines. |
|
Scientific Title of Study
|
Prevalence of Dermatophytosis and their antifungal susceptibility pattern |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Drsarath chandar C |
| Designation |
MD Post Graduate |
| Affiliation |
Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem. |
| Address |
PG Room,
Department of Microbiology,
Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem.
Salem
TAMIL NADU
636308
India |
| Phone |
8220616414 |
| Fax |
|
| Email |
drsarath6009@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
DrAVRaghavendra rao |
| Designation |
professor |
| Affiliation |
Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem |
| Address |
Department of Microbiology,
Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem.
Salem
TAMIL NADU
636308
India |
| Phone |
8428395339 |
| Fax |
|
| Email |
dravrrao@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
DrAVRaghavendra rao |
| Designation |
professor |
| Affiliation |
Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem |
| Address |
Department of Microbiology,
Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem.
Salem
TAMIL NADU
636308
India |
| Phone |
8428395339 |
| Fax |
|
| Email |
dravrrao@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Dr Sarath Chandar C |
| Address |
PG Room, Department of microbiology,
vinayaka missions medical college and hospitals,salem |
| Type of Sponsor |
Other [self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sarath chandar C |
vinayaka missions kirupananda variyar medical college and hospitals |
pg room,department of microbiology,vinayaka missions kirupananda variyar medical college and hospitals,salem
Salem
TAMIL NADU |
8220616414
drsarath6009@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: B358||Other dermatophytoses, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Antifungal susceptibility pattern for Dermatophytosis case |
Antifungal susceptibility for drugs Itraconazole,Terbinafine, Griseofulvin, Fluconazole. Total duration- 2 years |
|
|
Inclusion Criteria
|
| Age From |
1.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Clinically suspected cases of dermatophytosis of all age groups attending Dermatology OPD |
|
| ExclusionCriteria |
| Details |
Patients with non dermatyophytic fungal infections |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To determine the most prevalent dermatophyte species isolated from patients attending the hospital |
2 years |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To assess the antifungal susceptibility pattern of dermatophyte isolates to commonly used anttifungal agents |
2 years |
|
|
Target Sample Size
|
Total Sample Size="90"
Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
23/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2"
Months="0"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This is a cross sectional , open labelled study on detecting the antifungal susceptibility profile of Dermatophytosis patients for the following drugs Itraconazole, Terbinafine, Griseofulvin, Fluconazole. identification of most prevalent dermatophyte species in this hospital and insight in to emerging antifungal resistance patterns. |